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Purpose: We report our experience to date with 171 patients who underwent lapa-
roendoscopic single-site surgery for diverse urologic diseases in a single institution.
Materials and Methods: Between December 2008 and August 2010, we performed 171 
consecutive laparoendoscopic single-site surgeries. These included simple nephrectomy 
(n=18; robotic surgeries, n=1), radical nephrectomy (n=26; robotic surgeries, n=2), par-
tial nephrectomy (n=59; robotic surgeries, n=56), nephroureterectomy (n=20; robotic 
surgeries, n=12), pyeloplasty (n=4), renal cyst decortications (n=22), adrenalectomy 
(n=4; robotic surgeries, n=2), ureterolithotomy (n=10), partial cystectomy (n=3), ure-
terectomy (n=1), urachal mass excision (n=1), orchiectomy (n=1), seminal ves-
iculectomy (n=1), and retroperitoneal mass excision (n=1). All procedures were per-
formed by use of a homemade single-port device with a wound retractor and surgical 
gloves. A prospective study was performed to evaluate outcomes in 171 cases.
Results: Of the 171 patients, 98 underwent conventional laparoendoscopic single-site 
surgery and 73 underwent robotic laparoendoscopic single-site surgery. Mean patient 
age was 53 years, mean operative time was 190.8 minutes, and mean estimated blood 
loss was 204 ml. Intraoperative complications occurred in seven cases (4.1%), and post-
operative complications in nine cases (5.3%). There were no complications classified 
as Grade IIIb or higher (Clavien-Dindo classification for surgical complications). Con-
version to mini-incision open surgery occurred in seven (4.1%) cases. Regarding onco-
logic outcomes, no cancer-related events occurred during follow-up other than one ag-
gressive progression of Ewing sarcoma.
Conclusions: Laparoendoscopic single-site surgery is technically feasible and safe for 
various urologic diseases; however, surgical experience and long-term follow-up are 
needed to test the superiority of laparoendoscopic single-site surgery.
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INTRODUCTION
The introduction of laparoscopic procedures has revolu-
tionized surgery, paving the way for minimally invasive 
procedures. To improve safety, outcomes, and cosmesis, and 
to further reduce invasiveness, laparoendoscopic single- 
site surgery (LESS) has been developed for endourology. 
After Raman et al performed the first urologic LESS [1], 
this technique has been used for various urologic diseases 
[2-7] and has gradually been extended to pediatric cases 
[8-10]. Researchers have reported the feasibility and short- 
term outcomes of LESS with their own modifications; how-
ever, to our knowledge, there have been no reports on the 
large-scale use of LESS procedures in Asia [2-4,11]. There-
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FIG. 1. Conventional laparoendoscopic single-site surgery. (A) A homemade single-port device and laparoscopic instruments for right
radical nephrectomy. (B) Renal hilar dissection with articulating hook electrocautery. (C) Ureteropelvic reconstruction with a straight
laparoscopic needle holder. We used the first stitch string for internal traction of the ureter. A double-J stent was inserted in the distal
ureter; the proximal coil was not yet inserted. (D) Urachal mass excision using an additional 2 mm MiniLap Alligator clamp (Stryker,
NY, USA, left).
fore, we present 171 consecutive cases of urologic LESS, in-
cluding robotic procedures, in which our homemade port 
device was used.
MATERIALS AND METHODS
From December 2008 to August 2010, 171 cases of LESS 
were performed in our institution. Conventional LESS 
(C-LESS) and robotic LESS (R-LESS) were performed by 
three expert laparoscopic surgeons. The disease-specific 
inclusion and exclusion criteria for LESS were the same as 
for conventional laparoscopic surgery. Patients were given 
a choice of conventional laparoscopy, C-LESS, R-LESS, or 
open surgery. We described the expected surgical and post-
operative outcomes, including pain and incisional wounds, 
with our own data and photographs. We also explained the 
advantages and disadvantages of LESS and its cost com-
pared with other surgery types. We performed LESS only 
when the patients provided written consent. Patients were 
followed up with the appropriate studies. Cancer patients 
were evaluated by computed tomography (CT) or positron 
emission tomography-CT (PET-CT) at 3, 6, and 12 months 
after surgery, and then every 6 months if there was no evi-
dence of recurrence or metastasis. Postoperative complica-
tions were classified according to the Clavien-Dindo classi-
fication for surgical complications [12]. We analyzed in-
dications and perioperative outcomes. The present study 
was approved by the institutional review board at Yonsei 
Severance Hospital, Seoul, Korea.
　Through the 2 to 5 cm umbilical incision, we placed the 
port device with a size 7 powder-free surgical glove and 
wound retractor for both C-LESS and R-LESS. For C- 
LESS, a total of three or four trocars (12 mm and 5 mm) were 
used (Fig. 1A). In C-LESS, a 10 mm 30o rigid laparoscope 
(Stryker, Kalamazoo, MI, USA) with integrated camera 
and right-angled light cable adaptor was used. In some cas-
es, an additional 5 mm or 2 mm trocar was used for liver 
retraction or pelvic surgery [3]. We used conventional lapa-
roscopic instruments and flexible articulating laparo-
scopic instruments depending on the type of procedure. 
Straight retractor devices were typically used for kidney 
and ureteral dissection without difficulty. Articulating de-
vices such as hook cautery and scissors were used with the 
dominant hand only for renal vascular dissection, upper 
posterior kidney dissection, and adrenal dissection. 
　The homemade single-port system was placed for R- 
LESS (da Vinci S, Intuitive Surgical, Sunnyvale, USA) as 
it was for C-LESS. Two 12 mm trocars and two 5 mm trocars 
were used. The camera was inserted through the 12 mm 
trocar and the robot arms were inserted thorough the 8 mm 
port [13]. In most cases, an additional trocar was inserted 
alongside the port device to create a 12 mm hybrid port. To 
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FIG. 2. Robotic laparoendoscopic single-site partial nephrectomy. (A) A homemade single-port device was established by inserting two
12 mm trocars and two 8 mm trocars through the fingers of the surgical gloves. The scope was placed at a 30o upward angle to the robotic
arms. (B) Renal vessel clamping.
FIG. 3. Abdomen 1 month after surgery.
prevent the outer clashing of robotic arms, the scope was 
placed at a 30o upward angle to the robotic arms (Fig. 2A) 
[13]. We maintained intra-abdominal pressure under 12 
mmHg and checked the glove to ensure that it did not 
inflate. All surgical procedures were performed with the 
homemade single-port device (Fig. 1B-D, 2B).
RESULTS
Between 2008 and 2010, 171 patients underwent C-LESS 
(n=98) or R-LESS (n=73) for various urologic diseases 
(male, n=94 [55%]; female, n=77 [45%]). Mean patient age 
was 53 years (range, 1-86 years), and mean body mass in-
dex was 23.7 kg/m2 (range, 14.3-32.9 kg/m2). Thirty-three 
patients (19.3%) had undergone previous abdominal sur-
gery, and seven cases were converted to mini-incision open 
surgery owing to severe adhesions from previous surgery 
(C-LESS, n=3; R-LESS n=2), failure to identify endophytic 
renal mass even by intraoperative ultrasonogram (R-LESS 
n=1), or inferior vena cava injury (C-LESS n=1). Mean op-
erative time was 190.8 min (range, 20-440 min), and mean 
ischemic time for partial nephrectomy was 26 min (range, 
11-65 min). Mean estimated blood loss (EBL) was 204 ml 
(range, ＜10-2,700 ml), and the total transfusion rate was 
9%. The mean hospital stay was 4.5 days (range, 1-19 days). 
Intraoperative complications occurred in seven cases (4.1%): 
diaphragm injury during C-LESS radical nephrectomy 
(n=2), bowel injury during C-LESS partial nephrectomy 
and R-LESS simple nephrectomy (n=2), inferior vena cava 
injury during C-LESS simple nephrectomy (n=1), renal 
vein injury (n=1), and ureter injury during R-LESS partial 
nephrectomy (n=1).
　An additional port was used for seven right renal sur-
geries and one pelvic surgery during C-LESS (4.7%). Most 
R-LESS procedures used an additional hybrid port except 
for simple and radical nephrectomies. Postoperative com-
plications occurred in nine patients (5.3%). Wound de-
hiscence (Clavien-Dindo Grade I) occurred in three pa-
tients; however, they did not require secondary closure. 
One patient suffered from prolonged ileus after C-LESS 
(Grade I), but recovered and was discharged according to 
schedule. Acute renal failure (Grade I) developed immedi-
ately after R-LESS nephroureterectomy, but patients re-
covered with hydration and diuretics. One patient required 
a transfusion for postoperative bleeding (Grade II). After 
C-LESS nephroureterectomy, one patient developed a ret-
roperitoneal abscess on postoperative day 8 and was treat-
ed with antibiotics (Grade II). One retroperitoneal abscess 
(Grade IIIa) was detected on postoperative day 11 after 
R-LESS nephroureterectomy and was treated with anti-
biotics and pigtail drainage for 8 days. In one C-LESS pyelo-
plasty, the ureteral catheter migrated downward on post-
operative day 4 (Grade IIIa); the patient reported flank 
pain, so we exchanged the ureteral catheter. No grade IIIb, 
IV, or V (death) complications were reported. Surgical 
scars were almost undetectable within a few months after 
surgery (Fig. 3).
　Regarding oncologic outcomes, two cases with focal posi-
tive margins underwent R-LESS partial nephrectomy. In 
these cases, intraoperative analysis of frozen sections was 
negative, and no evidence of recurrence was found at the 
1-month or 6-month follow-up CT evaluations of either 
patient. One patient who underwent C-LESS radical neph-
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TABLE 1. Procedures, surgical indication or diagnosis, and perioperative results for LESS (n=171)
Procedures n Surgical indication or diagnosis
Mean 
size 
(cm)
Mean 
OR 
time 
(min)
Mean 
EBL 
(ml)
Mean
HS
(day)
Trans-
fusion
 rate 
(%)
Comments
Simple nephrectomy
2008 Desai et al [4] 14 Benign nonfunctioning 
kidney
- 145 109 2 0 All cases morcellated and extracted 
Additional port (5; 41%)
2008 White et al [2] 7 Nonfunctional renal unit - 156 121 2.3 0 No complications
2009 Raybourn et al
[16]
11 Atrophic nonfunctioning 
kidney
- 151 51 32 0 Port site bruising (1), pyrexia (1)
2010 Present study 
C-LESS
17 Benign nonfunctioning 
kidney 
- 221 328 5.5 18 IVC injury: mini-incision open conversion 
(1)
Additional port for liver traction (2)
Ileus (1)
R-LESS 1 Benign nonfunctioning 
kidney
- 128 100 7.0 0 Bowel injury (1), no additional port
Radical nephrectomy
2008 Desai et al [4] 3 RCC - 208 200 3.5 0 Gonadal vein avulsion (1)
Transvaginal extraction (1)
Additional port
2008 White et al [2]
C-LESS (5) 
R-LESS (1)
6 Enhanced renal mass 
suggesting malignancy 
4.6 206 146 2.3 17 Intensive care unit admission for post-
operative bleeding and embolization (1)
2009 Stolzenburg 
et al [17]
10 RCC 5.2 146.4 202 - 10 Bleeding requiring transfusion (1)
2010 Present study 
C-LESS
24 RCC (21)
Urothelial carcinoma, 
pelvis (1)
Ewing sarcoma (1),
Mixed epithelial and 
stromal tumor (1)
4.8 209 289 5.7 17 Diaphragm injury (2)
Mini-incision open conversion (1)
Wound dehiscence (1)
Additional port for liver traction (2)
R-LESS 2 RCC (1)
Leiomyosarcoma (1)
9.0 248 225 4.7 0 Mini-incision open conversion (1)
No additional port
Partial nephrectomy
2008 Desai et al [4] 6 RCC (2)
AML (1)
Oncocytoma (1)
- 271 475 7.2 0 Laparoscopic conversion (1)
Postoperative bleeding - angioembolization 
(1)
Additional port, negative margins 
2008 White et al [2]
C-LESS (11) 
R-LESS (4)
15 Enhancing renal mass 
suggesting malignancy
3.01 196 422 4.5 27 Conversion (2), 
Positive margins (1)
2008 Aron et al [18] 5 RCC (3) 
Oncocytoma (2)
3 270 150 3 0 Postoperative hemorrhage and pulmonary
embolism (1), negative margins 
2008 Kaouk et al 
[19] 
C-LESS
5 RCC (6) 
Benign cyst (1)
2.1 160 420 3.2 - Focally positive margin (1)
Conversion to laparoscopy (1)
No additional port
R-LESS 2 2.0 170 100 3.5 0 No complications, negative margins 
No additional port
2010 Present study 
C-LESS
3 RCC (1)
AML(1)
Metanephric adenoma in 
a child (1)
2.5 226 70 4.3 0 Bowel injury (1)
Mini-incision open conversion (1)
Margins negative, 
Mean ischemic time 29 min
Additional port for liver traction (1)
R-LESS 56 RCC (49)
AML (3)
Oncocytoma (1)
Other (3)a
2.8 198 273 4.7 13 Mini-incision open conversion (2)
Renal vein injury (1), ureter injury (1)
Postoperative bleeding (1)
Positive margins (2)b
Mean ischemic time 26 min, Hybrid port
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TABLE 1. Continued
Procedures n
Surgical indication or 
diagnosis
Mean 
size 
(cm)
Mean 
OR 
time 
(min)
Mean 
EBL 
(ml)
Mean
HS
(day)
Trans-
fusion
 rate 
(%)
Comments
Nephroureterectomy
2008 Desai et al [4] 2 Urothelial carcinoma (1)
Reflux＋recurrent 
pyelonephritis (1)
- 90 75 5 0 Distal ureter: cystoscopic resection＋ 
laparoscopic EndoGIA
No complications, additional port (2)
2008 White et al [2]
C-LESS (6) 
R-LESS (1)
7 Urothelial carcinoma 2.73 198 396 3.9 14 Conversion (1)
2010 Present study 
C-LESS
8 Urothelial carcinoma (5)
Vesicoureteral reflux in a 
child (2)
Ectopic ureter in a child (1)
3.3 315 103 7.4 0 Retroperitoneal abscess (1)
Additional port for liver traction (2)
R-LESS 12 Urothelial carcinoma (10)
RCC (2)
2.5 227 248 4.1 17 Acute renal failure (1)
Retroperitoneal abscess (1), hybrid port
Pyeloplasty
2008 Desai et al [4] 
C-LESS (15) 
R-LESS (2)
17 Primary ureteropelvic 
junction obstruction
- 236 79 2 0 Laparoscopic conversion (1)
Additional port success rate: 15/16 
93.5%; follow-up data available for 
16/19
2008 White et al [2]
C-LESS (7) 
R-LESS (1)
8 Ureteropelvic junction 
obstruction
- 233 62.5 3.4 0 Hernia (1)
2009 Tracy et al [20] 15 Ureteropelvic junction 
obstruction and delayed 
urinary excretion based on 
functional imaging
- 202 35 77 5 Hematuria, urine leak, clot obstruction
(5)
2010 Present study 
C-LESS
4 Ureteropelvic junction 
obstruction 
- 196 80 4.5 0 Stent migration (1)
Renal cyst decortications
2008 Desai et al [4] 1 Extrinsic compression and 
ureteropelvic junction 
obstruction
- 60 ＜50 1 0 No complications
Additional port
2008 White et al [2] 2 Symptomatic renal cyst - 135 50 1.5 0 No complications
2009 Ryu et al [21] 5 Large renal cyst - 56 178.8 5.2 0 Wound dehiscence (1)
2010 Present study 
C-LESS
22 Symptomatic renal cyst 6.0 93 20 2.2 0 No complications 
Transperitoneal (19), 
Retroperitoneal (3)
Adrenalectomy
2008 Desai et al [4] 1 Adrenal mass - 150 650 3 0 Laparoscopic conversion (1)
Renal vein injury (1)
Additional port
2009 Jeong et al 
[22]
9 Pheochromocytoma (5)
Nonfunctioning adenoma (3)
Cushing’s syndrome (1)
2.8 169.2 177.8 77 0 Small bowel injury (1)
2010 Present study 
C-LESS
2 Pheochromocytoma (1)
Leiomyosarcoma (1)
5.7 260 125 3.0 0 No complications
R-LESS 2 Pheochromocytoma (1)
Nonfunctioning adenoma (1)
2.5 167 250 3.5 0 No complications
Hybrid port
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TABLE 1. Continued
Procedures n
Surgical indication or 
diagnosis
Mean 
size 
(cm)
Mean 
OR 
time 
(min)
Mean 
EBL 
(ml)
Mean
HS
(day)
Trans-
fusion
 rate 
(%)
Comments
Other C-LESS procedures in the present study
Ureterolithotomy 10 Ureter stone 1.8 162 70 3 0 Wound dehiscence (1)
Mini-incision open conversion (1)
Partial cystectomy 3 Urachal remnant (2)
Leiomyoma (1)
3.5 171 50 3.3 0 No complications
Ureterectomy 1 Duplication of ureter 
(ectopic ureter)
- 80 150 3 0 Wound dehiscence (1)
Urachal mass 
excision
1 Urachal remnant 1.5 100 ＜10 3 0 Additional 2 mm port (1)
Orchiectomy 1 Cryptorchidism - 20 ＜10 2 0 No complications
Seminal 
vesiculotomy
1 Seminal vesicle cyst 4.4 110 ＜10 2 0 No complications
Retroperitoneal 
mass excision
1 Cystic lymphangioma 6.4 99 30 6 0 No complications
LESS: laparoendoscopic single-site surgery, OR: operating room, EBL: estimated blood loss. HS: hospital stay, IVC: inferior vena cava,
RCC: renal cell carcinoma, AML: angiomyolipoma, a: xanthomatous pyelonephritis (n=1), metanephric adenoma (n=1), hemorrhagic
cyst (n=1), b: focally positive on final pathology. Intraoperative analysis of frozen section was negative.
rectomy eventually received a diagnosis of Ewing sarcoma; 
multiple lymph node metastasis and bone metastasis were 
detected within 2 months. Other than this case, no re-
currence or metastasis was reported during follow-up 
(mean follow-up, 9.4 months). Even leiomyosarcoma, which 
was treated by C-LESS adrenalectomy, had not recurred 
by the 15-month follow-up. Perioperative outcomes and 
specific comments regarding each type of surgery are shown 
in Table 1.
DISCUSSION
In recent decades, laparoscopic surgery has undergone 
rapid technical development and advances in laparoscopic 
instruments. The aims of laparoscopic surgery include 
minimal invasiveness, safety, and cost-effectiveness; thus, 
laparoscopic surgeons have worked to continuously im-
prove the surgical techniques. A result of these efforts is 
the nearly scarless technique, LESS [1]. The last 3 years 
have witnessed a rapid expansion of LESS for various uro-
logic diseases. To evaluate LESS, worldwide experiences 
have been reported [14], including large-scale studies con-
ducted in a single institution. Table 1 compares the out-
comes of previous studies with our data [2,15-22]. Desai et 
al performed a total of 100 LESS procedures including sim-
ple prostatectomy (32%), donor nephrectomy (17%), pyelo-
plasty (17%), simple nephrectomy (14%), and partial neph-
rectomy (6%) [4]. White et al reported the same number of 
LESS procedures including donor nephrectomy (19%), par-
tial nephrectomy (15%), sacral colpopexy (13%), and renal 
cryotherapy (8%) [2]. Indications for LESS in the present 
study differed somewhat from those of the previous 
studies. In our study, more than half of the LESS proce-
dures were performed for malignancies, 59 (34.5%) of the 
LESS cases were performed for partial nephrectomy, and 
26 (15.2%) for radical nephrectomy. However, this differ-
ence may be due to different patient populations rather 
than the surgeons’ preferences.
　The ideal indications for LESS may be pediatric urologic 
diseases and benign diseases for which cosmetic outcomes 
are important. Park et al and Marietti et al have reported 
outcomes for C-LESS in simple nephrectomies for pediatric 
cases of nonfunctioning kidney [8,10]. In the present study, 
four pediatric patients underwent C-LESS: two nephrour-
eterectomies for nonfunctioning kidney, one partial neph-
rectomy for metanephric adenoma, and one ureterectomy 
for ectopic ureter were successfully performed without 
complications. Anecdotally, their parents seemed ex-
tremely satisfied with the postoperative cosmetic results. 
Similarly, surgeries that require smaller incisions for 
specimen extraction appear to be good indications for 
LESS. Patients are more concerned with cosmesis in 
non-life-threatening diseases such as ureteropelvic junc-
tion obstruction, renal cyst, or ureteral stone. In addition, 
these surgical procedures do not require a wide surgical 
field, and the specimens are smaller than the single-port 
device. Ryu et al achieved favorable results using LESS for 
renal cyst decortications [21]. We have expanded the use 
of LESS to pyeloplasty, ureterolithotomy, and other benign 
surgeries such as urachal mass excision, orchiectomy, 
seminal vesiculotomy, and retroperitoneal mass excision, 
as shown in Table 1. Comparing the indications for C-LESS 
and R-LESS, R-LESS was more suitable for technically de-
manding procedures requiring meticulous intracorporeal 
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suturing such as partial nephrectomy and bladder cuff 
resection. On the other hand, C-LESS is relatively suitable 
for simple and radical nephrectomy, renal cyst decortica-
tions, ureterolithotomy, and pediatric surgery because 
these can be comfortably performed without the expensive 
robot assistance even with standard laparoscopic instru-
ments. For partial nephrectomy, we preferred to use R- 
LESS (94%), because the robotic EndoWrist and hybrid 
port technique was more convenient and safe for upper pos-
terior renal dissection and hilar management. With this 
system, we could also perform the meticulous suturing for 
renorrhaphy without difficulty [3,9,13]. In the first C- 
LESS nephroureterectomy, we used the Endo-GIA stapler 
for bladder repair. Even with stay sutures, deep bladder 
cuff resection using the laparoscopic endoshears (inclu-
ding detrusor muscle as previously reported) was some-
what difficult in C-LESS [23]. In contrast, robotic assis-
tance could make a deep bladder cuff resection and con-
venient suturing of the bladder defect. However, lymph 
node dissection was not performed in all nephroureter-
ectomy cases, because only low-grade tumors were selec-
ted.
　The operative outcomes of the present study were com-
parable to those of previous studies (Table 1). However, in 
partial nephrectomy, the mean EBL of our C-LESS proce-
dures (70 ml) was noticeably less than that of other studies 
(150-475 ml) [2,4,18,19]. In contrast, the mean EBL of 
R-LESS procedures (273 ml) was greater than that re-
ported by a previous study (100 ml) [19], but was still small-
er than that of C-LESS procedures in other studies. These 
differences may not be due to differences in technical skill, 
but may be the result of different surgical indications. 
When we began treating partial nephrectomies with 
C-LESS, we limited the procedure to exophytic anterior 
lower pole masses. After the transition to R-LESS, we grad-
ually expanded the indication to endophytic and upper pos-
terior masses, because R-LESS enables more accurate su-
turing and safer hilar and upper pole management. The 
mean EBL for C-LESS simple nephrectomy was larger 
than that reported in other studies, and larger than that 
of radical nephrectomy and even partial nephrectomy in 
our study, because of three cases: the surgeon’s first LESS 
case, inferior vena cava injury in one case, and multiple re-
nal vessels in one case. Apart from these three cases, the 
EBL was comparable (159 ml). 
　Intraoperative safety is the most important concern in 
laparoscopic surgery. White et al reported that no intra-
operative complications occurred in 100 cases [2]. Another 
study of renal and ureteral LESS reported the same out-
come [21]. However, Desai et al reported 4/100 (4%) intra-
operative complications that included gonadal vein avul-
sion, bowel injury, bleeding requiring sutures, and renal 
vein injury [4]. In the present study, seven intraoperative 
complications (4.1%) occurred, and one case (inferior vena 
cava injury) was converted to mini-laparotomy (6 cm). The 
total conversion rate (7/171 [4.1%]) was lower than that of 
the two previous studies with 100 cases (conversion rates, 
6% and 7%) [2,4]. Intraoperative accidents were not the 
most common reason for conversion. We were able to suc-
cessfully manage intraoperative accidents without con-
version by effective internal retractions through our home-
made port device. This was possible because the glove used 
for the port device provided a wide range of motion, and var-
ious trocar sizes could be used. In addition, the residual fin-
ger space in the gloves, which replaced a retrieval bag for 
sealing the small specimen, provided more room for im-
portant procedures. In the present study, most of the intra-
operative accidents occurred in our first 30 cases and dur-
ing partial nephrectomy. This finding suggests that even 
experienced surgeons experience some difficulty adapting 
to the single port. In addition, partial nephrectomy, which 
requires meticulous parenchymal suturing and careful 
vascular control, is as challenging a technique in LESS as 
it has been in conventional laparoscopy and robotic 
surgery. 
　We compared our postoperative complications with 
those of two other studies. Desai et al reported five cases 
(5%) of postoperative complications including urinary 
tract infection (Clavien-Dindo Grade II); postoperative 
bleeding requiring transfusion (Grade II), angioemboliza-
tion (Grade IIIa), and exploration (Grade IIIb); and one 
mortality (Grade IV) [4]. White et al reported 10 cases (10%) 
of postoperative complications with seven cases of blood 
transfusion (Grade II), urinary tract infection (Grade II), 
rectovesical fistula requiring operation (Grade IIIb), and 
readmission to the intensive care unit and angioemboliza-
tion due to postoperative bleeding in partial nephrectomy 
cases (Grade IVa) [2]. Although it is difficult to compare 
outcomes from different types of surgery, the postoperative 
complication rate of the present study (5.3%) was similar 
to or lower than the rates of previous studies, and the com-
plications in the present study were less severe.
　The duration of follow-up in the present study was not 
sufficient to evaluate oncologic outcomes (9.4 months). 
However, no cancer-related events were observed other 
than progression of Ewing sarcoma in one case. Long-term 
follow-up data must be analyzed and compared with re-
sults from conventional laparoscopic surgery and open 
surgery.
　LESS is an attractive surgical modality that has ad-
vanced the ultimate aim of minimally invasive surgery; 
however, aspects of LESS can be improved. First, a sutur-
ing technique is needed that allows meticulous suturing of 
renal parenchyma and various anastomoses. The conven-
tional triangular arrangement of instruments is not used 
in LESS; therefore, some conventional laparoscopic suture 
techniques cannot be performed. Second, because LESS is 
increasing continuously, standard indications are needed 
for each LESS procedure. LESS is still a challenging tech-
nique; accordingly, leading laparoscopic surgeons should 
be responsible for establishing indications. Finally, a ro-
botic system specialized for single-port surgery is needed. 
The currently available robotic systems were not devel-
oped for LESS procedures. For this reason, instrumental 
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clashing was unavoidable, and we used a hybrid port 
technique. With these changes, the LESS procedure will 
become safer and more convenient for surgeons. 
　There were several limitations to this study. We did not 
attempt to evaluate the superiority of LESS over conven-
tional laparoscopy or robotic surgery. In addition, cosmetic 
outcomes and quality of life data were not evaluated. To 
overcome these limitations, additional surgical experi-
ence, longer follow-up, and large-scale randomized con-
trolled trials are needed.
CONCLUSIONS
We presented 171 cases of urologic LESS procedures per-
formed with the use of a homemade single-port device. We 
have demonstrated that LESS is feasible and can be safely 
applied to a variety of urologic operations, although LESS 
is still a challenging technique for urologic conditions. 
Long-term follow-up will be needed to prove the safety, 
cosmesis, and cost-effectiveness of LESS and provide a 
comparative analysis with other procedures to confirm the 
significant benefits of LESS. 
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